Further, in combination with serum PSA (cut-off of 10 ng/mL) and urinary PCA3, T2-ERG provides an improved accuracy in diagnosing prostate cancer with a sensitivity and specificity of 80% and 90%, respectively [73]. This evidence concerns the gene KLK3 and Familial prostate cancer.